PSMA and FDG PET/CT Findings in Patient With Dedifferentiated Liposarcoma and Prostate Cancer Metastases.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38689438.
- Also identified by DOI 10.1097/RLU.0000000000005252.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dedifferentiated liposarcoma is an extremely rare and highly malignant tumor. We demonstrated a case of a 75-year-old man with significantly PSMA-avid and mildly FDG uptake-dedifferentiated liposarcoma in the retroperitoneal area. The double-tracer (PSMA and FDG) PET scans could further contribute to differential diagnosis and the following treatment strategy for patients who were suspected with prostate cancer metastases and other malignant tumors simultaneously.
Medical subject headings
- Liposarcoma
- Prostatic Neoplasms
- Fluorodeoxyglucose F18
- Positron Emission Tomography Computed Tomography